Abatacept for Treatment of Recurrent or de Novo Autoimmune Hepatitis
Clinical trial NCT04203875 · TERMINATED
Trial details
- NCT number
- NCT04203875
- Sponsor
- Stuart Knechtle, M.D.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-09
- Primary completion
- 2020-07-23
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.